 |
INVESTOR HOME
PRESS RELEASES
PRODUCT DEMONSTRATIONS
EVENTS & WEBCASTS
ANNUAL MEETING
INVESTOR KIT
INFORMATION REQUEST
FAQs
|
|
2003 PRESS RELEASE ARCHIVE
October 15, 2003
ADVENTRX Pharmaceuticals, Inc. Enters into Agreement with Leading Contract Research Organization for Phase II Clinical Trials of CoFactor™
October 7, 2003
ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw Techvest Healthcare Conference
October 2, 2003
ADVENTRX Pharmaceuticals Expands Preclinical Testing of second generation HIV Viral Entry Inhibitor
September 23, 2003
ADVENTRX Pharmaceuticals Expands HIV Antiviral Platform through development of Thiovir™
September 16, 2003
ADVENTRX Pharmaceuticals Raises $2.5 Million Through a Private Placement
August 6, 2003
ADVENTRX Pharmaceuticals, Inc. Announces Formation of Scientific Advisory Board
July 22, 2003
ADVENTRX Pharmaceuticals, Inc. announces its Contract Research Organization Agreement for Phase Ib/IIa clinical trials for its HIV viral entry inhibitor
June 26, 2003
ADVENTRX PHARMACEUTICALS, Inc. Announces Plans for Phase Ib/IIa Human Clinical Trail in HIV
June 13, 2003
Biokeys Pharmaceuticals Changes Name to ADVENTRX Pharmaceuticals, Inc. Company To Trade Under the Bulletin Board Symbol AVRX
June 11, 2003
Biokeys Pharmaceuticals, Inc. commences manufacturing of BlockAide/CR™ – Company Seeks to Duplicate Preclinical success in third quarter Phase Ib/IIa HIV Clinical Trial
June 5, 2003
Biokeys Pharmaceuticals, Inc. announces that it has initiated manufacturing of its Colorectal Cancer drug for Phase II human trials - Company Seeks to Replicate Success of Swedish Trials
May 28, 2003
Biokeys Pharmaceuticals, Inc. Completes Private Placement of Common Stock and Warrants
March 20, 2003
CEOcast Features Biokeys Pharmaceuticals' CEO
March 18, 2003
Research study discloses evidence that Biokeys Pharmaceuticals' viral entry inhibitor therapeutically targets diverse HIV-I strains
March 14, 2003
Biokeys Pharmaceuticals Inc. Hires Chief Technical Officer
February 10, 2003
Biokeys Pharmaceuticals Inc. Announces Management Addition and Auditor Change
|
|
|
